Skip to main content
. 2001 Sep;69(9):5864–5873. doi: 10.1128/IAI.69.9.5864-5873.2001

TABLE 1.

Bacterial strains, plasmids, and bacteriophages used in this study

Strain, plasmid, or bacteriophage Descriptiona Reference or source
E. coli
 260-1 LT CFA/III 12
 31-10 LT CFA/III 13
 31-10P CFA/III-negative spontaneous derivative of strain 31-10; LT This study
 HB101 Host for recombinant plasmids Laboratory stock
 JM109 Host for recombinant M13 bacteriophages Laboratory stock
Plasmid
 pSH1134 32.5-kb plasmid containing CFA/III gene cluster and Tn3 insertion; Apr 32
 pTT201 pMW119 (AccI and BamHI sites) containing 8.6-kb ClaI1-BamHI1 fragment from pTT202; Apr 40
 pTT202 pMW119 (AccI site) containing 11.5-kb ClaI1-ClaI2 fragment from pSH1134; Apr 32, 40
 pTT206 pACYC184 (BamHI site) containing 12.4-kb BamHI1-BamHI2 fragment from pSH1134; Cmr 32, 41
 pTT222 pACYC184 (EcoRI site) containing 5.2-kb EcoRI2-EcoRI3 fragment from pTT206; Tcr 41
 pTT224 pACYC184 (SalI and BamHI sites) containing 7.6-kb SalI4-BamHI2 fragment from pTT206; Tcr 41
 pTT237 pMW119 (KpnI and AccI sites) containing 9.0-kb KpnI-ClaI2 fragment from pTT202; Apr This study
 pMW119 Cloning vector; AprlacZ Nippon Gene
 pACYC184 Cloning vector; Cmr Tcr Nippon Gene
Bacteriophage
 M13mp18 Cloning vector; lacZ Laboratory stock
 M13mp19 Cloning vector; lacZ Laboratory stock
a

Apr, Cmr, and Tcr, ampicillin, chloramphenicol, and tetracycline resistance, respectively.